Skip to main content
DGNX
NASDAQ Technology

Diginex Acquires The Remedy Project to Bolster ESG and Supply Chain Solutions

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$2.72
Mkt Cap
$537.187M
52W Low
$0.45
52W High
$39.855
52W Position info
504% above low
Off High info
93% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

DGNX has more than doubled off its 52-week low of $0.45 on elevated volume (2.3× avg).

Summary

Diginex has completed the acquisition of The Remedy Project, an ESG advisory firm, for an initial $3.79 million in shares and potential earn-outs, aiming to expand its sustainable supply chain solutions.


Key Events · M&A and Partnerships · DGNX

  • Strategic Acquisition Closed

    Diginex acquired 100% of The Remedy Project Limited, a Hong Kong-based ESG advisory company specializing in human rights due diligence and worker rights.

  • Consideration Details

    The initial payment involved the issuance of 1,000,000 Diginex ordinary shares, valued at $3.79 million ($3.79 per share) at the time of the transaction.

  • Performance-Based Earn-Out

    Up to an additional 1,000,000 Diginex ordinary shares are contingent on The Remedy Project meeting specific adjusted EBITDA targets over the next three years.

  • Enhanced ESG Offerings

    The acquisition combines Diginex's advanced supply chain technology with The Remedy Project's expertise, creating a comprehensive ecosystem for businesses to achieve resilient, ethical operations and comply with global ESG regulations.


Analysis · DGNX · Technology

Diginex's acquisition of The Remedy Project significantly enhances its ESG and supply chain technology offerings by integrating specialized human rights due diligence and remediation expertise. This strategic move positions Diginex to capitalize on growing global demand for ethical supply chain management and compliance with evolving regulations like the EU Corporate Sustainability Due Diligence Directive. The deal involves a notable share issuance, with further shares contingent on future performance, indicating a growth-oriented acquisition.

At the time of this filing, DGNX was trading at $2.72 on NASDAQ in the Technology sector, with a market capitalization of approximately $537.2M. The 52-week trading range was $0.45 to $39.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DGNX - Latest Insights

DGNX
Jul 06, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.53 info
Change: +$0.3298 (+27%) info
Market Cap: $43.942M info
DGNX
Jun 17, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.9602
Real-time Price: $1.53 info
Change: +$0.5696 (+59%) info
Market Cap: $43.942M info
DGNX
Jun 04, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $1.53 info
Change: +$0.4398 (+40%) info
Market Cap: $43.942M info
DGNX
Jun 03, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.20
Real-time Price: $1.53 info
Change: +$0.3322 (+28%) info
Market Cap: $43.942M info
DGNX
May 29, 2026, 4:59 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.44
Real-time Price: $1.53 info
Change: +$0.0898 (+6%) info
Market Cap: $43.942M info